Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Da Huo Luo Jiao Nang (大活络胶囊) is a traditional Chinese medicine (TCM) herbal formulation in capsule form developed and manufactured by Yaodu Zhangshu Pharmaceutical (a subsidiary of Renhe Group). It is a modern adaptation of the classic 'Da Huo Luo Wan' pill. The formulation contains a complex mixture of herbal ingredients, including red ginseng, white atractylodes, licorice, and prepared rehmannia root. It is primarily indicated for the treatment of ischemic stroke-induced hemiplegia, rheumatoid arthritis, muscle and tendon pain, and mobility impairment resulting from traumatic injuries. Its therapeutic mechanism, defined by TCM principles, involves dispelling wind, eliminating dampness and phlegm, and relaxing tendons to activate collaterals and relieve pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Da Huo Luo Jiao Nang.